Streetbeat News

Stock Prices

CLIK

Click Holdings shares have resumed trading after a temporary halt. The resumption of trading may impact the stock's short-term price movements.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:54 pm

CLIK

Click Holdings shares were halted due to a circuit breaker triggered by a significant drop in stock price. This indicates a potential issue or negative sentiment affecting the company.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:53 pm

CLIK

Click Holdings has begun trading on the stock market with shares priced at $4 each, following an IPO of 1.4 million shares.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:52 pm

AAPL

Analyst Ming-Chi Kuo reports that iPhone 16 Pro models are meeting demand expectations, while base models see slight order reductions. Overall production estimates for Q4 2024 are slightly lower than last year.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:52 pm

AFRM

Affirm Holdings (NASDAQ:AFRM) has seen significant options activity, with a mix of bullish and bearish trades. The stock price has risen by 5.72% to $43.51, and analysts have mixed ratings with price targets ranging from $37 to $68.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:49 pm

XOM

Exxon Mobil (NYSE:XOM) has seen significant bearish options activity, with 50% of investors adopting a bearish stance. The options activity suggests a price range of $115 to $130. Analysts have mixed ratings, with price targets ranging from $117 to $149.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:48 pm

UBER

Recent options trading trends for Uber Technologies show a bearish sentiment among major investors, with 66% of trades being bearish. Analysts have mixed ratings, with price targets ranging from $90 to $97. The stock is currently trading at $77.03, up 1.13%, but may be approaching overbought levels.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:48 pm

RVSN

Rail Vision shares surged following the announcement of a Standby Equity Purchase Agreement, allowing the company to sell up to $20 million in shares over three years.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:44 pm

NVAX

Novavax Inc (NASDAQ:NVAX) received European marketing authorization for its updated Nuvaxovid COVID-19 vaccine targeting the JN.1 variant. The vaccine is authorized for emergency use in the U.S. but not fully approved by the FDA. NVAX shares initially rose but then fell slightly.

Portfolio Pulse from Adam Eckert

October 09, 2024 | 2:43 pm